Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation.
Bioorg Med Chem Lett
; 22(21): 6583-6, 2012 Nov 01.
Article
en En
| MEDLINE
| ID: mdl-23031595
A series of potential DFMO prodrugs was designed through the incorporation of 4-nitrobenzyl ester or carbamate groups for potential activation by trypanosomal nitroreductase. It was found that only modification of N(ε)-amino group of DFMO by 4-nitro-2-fluorobenzyloxycarbonyl resulted in significant trypanocidal activity and could serve as a lead for further investigation.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Tripanocidas
/
Trypanosoma
/
Profármacos
/
Diseño de Fármacos
Idioma:
En
Revista:
Bioorg Med Chem Lett
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2012
Tipo del documento:
Article
País de afiliación:
Estados Unidos